ERBB2 and breast neoplasm: The field of microbiota research is gaining momentum in the field of HER2-positive breast tumors and interventional therapies to favor the microbiota, ranging from changes in diet, pre- and probiotics administration, or the more refined injection of engineered bacteria, may be encouraged [168].